Jayabharathi Vaidyanathan

425 total citations
13 papers, 319 citations indexed

About

Jayabharathi Vaidyanathan is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jayabharathi Vaidyanathan has authored 13 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Pharmacology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jayabharathi Vaidyanathan's work include Pharmacology and Obesity Treatment (5 papers), Pharmaceutical studies and practices (5 papers) and Diabetes Treatment and Management (4 papers). Jayabharathi Vaidyanathan is often cited by papers focused on Pharmacology and Obesity Treatment (5 papers), Pharmaceutical studies and practices (5 papers) and Diabetes Treatment and Management (4 papers). Jayabharathi Vaidyanathan collaborates with scholars based in United States. Jayabharathi Vaidyanathan's co-authors include Chandrahas Sahajwalla, Kenta Yoshida, Vikram Arya, Lei Zhang, Sang M. Chung, Lokesh Jain, Rajul K. Jain, Immo Zadezensky, Mona Khurana and Sandra Lau and has published in prestigious journals such as Journal of Pharmaceutical Sciences, Clinical Pharmacology & Therapeutics and Molecular Pharmaceutics.

In The Last Decade

Jayabharathi Vaidyanathan

12 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jayabharathi Vaidyanathan United States	6	106	96	79	62	41	13	319
Pajaree Chariyavilaskul Thailand	12	53 0.5×	40 0.4×	63 0.8×	60 1.0×	57 1.4×	53	424
Jennifer Victory United States	10	59 0.6×	52 0.5×	57 0.7×	67 1.1×	33 0.8×	23	340
Sumío Hirata Japan	15	83 0.8×	95 1.0×	62 0.8×	68 1.1×	77 1.9×	59	657
Yorki Tayrouz Germany	9	95 0.9×	90 0.9×	34 0.4×	68 1.1×	20 0.5×	12	343
Steven J. Kovacs United States	12	76 0.7×	95 1.0×	70 0.9×	129 2.1×	35 0.9×	19	469
Hiromitsu Imai Japan	13	182 1.7×	107 1.1×	87 1.1×	164 2.6×	34 0.8×	32	541
Molouk Hadjibabaie Iran	11	89 0.8×	38 0.4×	44 0.6×	22 0.4×	34 0.8×	32	414
Chandrahas Sahajwalla United States	14	88 0.8×	169 1.8×	118 1.5×	100 1.6×	76 1.9×	44	771
Dale K. Yu United States	12	148 1.4×	106 1.1×	70 0.9×	95 1.5×	26 0.6×	24	436
Zourong Ruan China	10	70 0.7×	36 0.4×	51 0.6×	73 1.2×	71 1.7×	34	374

Countries citing papers authored by Jayabharathi Vaidyanathan

Since Specialization

Citations

This map shows the geographic impact of Jayabharathi Vaidyanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayabharathi Vaidyanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayabharathi Vaidyanathan more than expected).

Fields of papers citing papers by Jayabharathi Vaidyanathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayabharathi Vaidyanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayabharathi Vaidyanathan. The network helps show where Jayabharathi Vaidyanathan may publish in the future.

Co-authorship network of co-authors of Jayabharathi Vaidyanathan

This figure shows the co-authorship network connecting the top 25 collaborators of Jayabharathi Vaidyanathan. A scholar is included among the top collaborators of Jayabharathi Vaidyanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayabharathi Vaidyanathan. Jayabharathi Vaidyanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wang, Yow‐Ming, et al.. (2024). Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological Products. The Journal of Clinical Pharmacology. 64(12). 1594–1605. 2 indexed citations

Chow, Edwin C.Y., et al.. (2024). Clinical Pharmacology of Glucagon. Clinical Pharmacology & Therapeutics. 116(4). 976–979.

Vaidyanathan, Jayabharathi, et al.. (2023). Predicting Food Effects on Oral Extended-Release Drug Products: A Retrospective Evaluation. The AAPS Journal. 25(3). 33–33. 2 indexed citations

Vaidyanathan, Jayabharathi, et al.. (2023). Inclusion of Subjects who are Obese in Drug Development: Current Status and Opportunities. The Journal of Clinical Pharmacology. 63(S2). S10–S17. 1 indexed citations

Vaidyanathan, Jayabharathi, et al.. (2023). Need for Representation of Pediatric Patients with Obesity in Clinical Trials. Children. 10(10). 1640–1640. 2 indexed citations

Vaidyanathan, Jayabharathi, et al.. (2022). Leveraging Clinical Pharmacology Data to Assess Biosimilarity and Interchangeability of Insulin Products. Clinical Pharmacology & Therapeutics. 113(4). 794–802. 4 indexed citations

Vaidyanathan, Jayabharathi, et al.. (2021). Pediatric Drug Development Studies for Familial Hypercholesterolemia Submitted to the US Food and Drug Administration Between 2007 and 2020. The Journal of Clinical Pharmacology. 62(3). 397–408. 2 indexed citations

Mehta, Mehul U., Ramana Uppoor, Dale P. Conner, et al.. (2017). Impact of the US FDA “Biopharmaceutics Classification System” (BCS) Guidance on Global Drug Development. Molecular Pharmaceutics. 14(12). 4334–4338. 25 indexed citations

Vaidyanathan, Jayabharathi, Kenta Yoshida, Vikram Arya, & Lei Zhang. (2016). Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1. The Journal of Clinical Pharmacology. 56(S7). S59–72. 89 indexed citations

10.

Chung, Sang M., et al.. (2015). Kidney function changes with aging in adults: comparison between cross‐sectional and longitudinal data analyses in renal function assessment. Biopharmaceutics & Drug Disposition. 36(9). 613–621. 12 indexed citations

11.

Vaidyanathan, Jayabharathi, Anshu Marathe, Nitin Mehrotra, et al.. (2015). Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimization. The Journal of Clinical Pharmacology. 55(6). 647–656. 8 indexed citations

12.

Vaidyanathan, Jayabharathi, et al.. (2012). Type 2 Diabetes in Pediatrics and Adults: Thoughts from a Clinical Pharmacology Perspective. Journal of Pharmaceutical Sciences. 101(5). 1659–1671. 15 indexed citations

13.

Jain, Rajul K., Sang M. Chung, Lokesh Jain, et al.. (2011). Implications of Obesity for Drug Therapy: Limitations and Challenges. Clinical Pharmacology & Therapeutics. 90(1). 77–89. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact